Prescribing Information & Guidance


Iron chelation agents for the management of iron overload in transfusion dependent low to intermediate 1 risk myelodysplastic syndrome (MDS)


Approved by BLMK APC July 2024

View Document

Guideline Categories: Haematology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: chelation, iron, iron overload, MDS, myelodysplastic syndrome

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net